
Ronald T. Niebauer
Examiner (ID: 12566, Phone: (571)270-3059 , Office: P/1676 )
| Most Active Art Unit | 1658 |
| Art Unit(s) | 1654, 1676, 1658, 1609 |
| Total Applications | 1040 |
| Issued Applications | 333 |
| Pending Applications | 129 |
| Abandoned Applications | 590 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19065697
[patent_doc_number] => 20240100123
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-28
[patent_title] => NOVEL AIMP1 PROTEIN FRAGMENT AND HAIR GROWTH-PROMOTING COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT
[patent_app_type] => utility
[patent_app_number] => 18/513026
[patent_app_country] => US
[patent_app_date] => 2023-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16311
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18513026
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/513026 | NOVEL AIMP1 PROTEIN FRAGMENT AND HAIR GROWTH-PROMOTING COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT | Nov 16, 2023 | Abandoned |
Array
(
[id] => 19510721
[patent_doc_number] => 20240342407
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-17
[patent_title] => INTRANASAL DESMOPRESSIN ADMINISTRATION
[patent_app_type] => utility
[patent_app_number] => 18/506719
[patent_app_country] => US
[patent_app_date] => 2023-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9019
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18506719
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/506719 | INTRANASAL DESMOPRESSIN ADMINISTRATION | Nov 9, 2023 | Abandoned |
Array
(
[id] => 19140537
[patent_doc_number] => 20240139329
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-02
[patent_title] => Targets for Receptor-Mediated Control of Therapeutic Biodistribution and Efficacy
[patent_app_type] => utility
[patent_app_number] => 18/495508
[patent_app_country] => US
[patent_app_date] => 2023-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35699
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18495508
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/495508 | Targets for Receptor-Mediated Control of Therapeutic Biodistribution and Efficacy | Oct 25, 2023 | Pending |
Array
(
[id] => 19157694
[patent_doc_number] => 20240150401
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-09
[patent_title] => INSECT NEUROPEPTIDES 7
[patent_app_type] => utility
[patent_app_number] => 18/492014
[patent_app_country] => US
[patent_app_date] => 2023-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20909
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18492014
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/492014 | INSECT NEUROPEPTIDES 7 | Oct 22, 2023 | Pending |
Array
(
[id] => 19564794
[patent_doc_number] => 12139556
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-12
[patent_title] => Insect neuropeptides 6
[patent_app_type] => utility
[patent_app_number] => 18/491976
[patent_app_country] => US
[patent_app_date] => 2023-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 20802
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18491976
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/491976 | Insect neuropeptides 6 | Oct 22, 2023 | Issued |
Array
(
[id] => 18842676
[patent_doc_number] => 20230405080
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING, PREVENTING, INHIBITING, AMELIORATING OR DELAYING THE ONSET OF OPHTHALMIC CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 18/460346
[patent_app_country] => US
[patent_app_date] => 2023-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38665
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18460346
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/460346 | METHODS AND COMPOSITIONS FOR TREATING, PREVENTING, INHIBITING, AMELIORATING OR DELAYING THE ONSET OF OPHTHALMIC CONDITIONS | Aug 31, 2023 | Pending |
Array
(
[id] => 18842720
[patent_doc_number] => 20230405124
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => GAMMA SECRETASE MODULATORS FOR THE TREATMENT OF IMMUNE SYSTEM DYSFUNCTION
[patent_app_type] => utility
[patent_app_number] => 18/241549
[patent_app_country] => US
[patent_app_date] => 2023-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15178
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18241549
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/241549 | GAMMA SECRETASE MODULATORS FOR THE TREATMENT OF IMMUNE SYSTEM DYSFUNCTION | Aug 31, 2023 | Pending |
Array
(
[id] => 19019019
[patent_doc_number] => 20240075190
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-07
[patent_title] => IODINATED CROSSLINKED HYDROGELS AND METHODS OF FORMING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/449907
[patent_app_country] => US
[patent_app_date] => 2023-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7717
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18449907
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/449907 | IODINATED CROSSLINKED HYDROGELS AND METHODS OF FORMING THE SAME | Aug 14, 2023 | Pending |
Array
(
[id] => 19156129
[patent_doc_number] => 20240148836
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-09
[patent_title] => COMPOSITION FOR TREATING CANCER EXPRESSING SPARC
[patent_app_type] => utility
[patent_app_number] => 18/233783
[patent_app_country] => US
[patent_app_date] => 2023-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5562
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18233783
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/233783 | COMPOSITION FOR TREATING CANCER EXPRESSING SPARC | Aug 13, 2023 | Pending |
Array
(
[id] => 19263660
[patent_doc_number] => 20240207357
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-27
[patent_title] => RECONSTITUTED HIGH DENSITY LIPOPROTEIN TREATMENT OF MYOCARDIAL INFARCTION
[patent_app_type] => utility
[patent_app_number] => 18/230058
[patent_app_country] => US
[patent_app_date] => 2023-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31085
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18230058
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/230058 | RECONSTITUTED HIGH DENSITY LIPOPROTEIN TREATMENT OF MYOCARDIAL INFARCTION | Aug 2, 2023 | Pending |
Array
(
[id] => 19111277
[patent_doc_number] => 20240123027
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-18
[patent_title] => APOMERS
[patent_app_type] => utility
[patent_app_number] => 18/360975
[patent_app_country] => US
[patent_app_date] => 2023-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15612
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18360975
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/360975 | APOMERS | Jul 27, 2023 | Pending |
Array
(
[id] => 19002061
[patent_doc_number] => 20240066132
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-29
[patent_title] => NOVEL FATTY ACIDS AND THEIR USE IN CONJUGATION TO BIOMOLECULES
[patent_app_type] => utility
[patent_app_number] => 18/352345
[patent_app_country] => US
[patent_app_date] => 2023-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56673
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18352345
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/352345 | NOVEL FATTY ACIDS AND THEIR USE IN CONJUGATION TO BIOMOLECULES | Jul 13, 2023 | Pending |
Array
(
[id] => 18895195
[patent_doc_number] => 20240010680
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-11
[patent_title] => PEPTIDE DISINFECTANT FOR PREVENTING CORONAVIRUSES
[patent_app_type] => utility
[patent_app_number] => 18/350803
[patent_app_country] => US
[patent_app_date] => 2023-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2709
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18350803
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/350803 | PEPTIDE DISINFECTANT FOR PREVENTING CORONAVIRUSES | Jul 11, 2023 | Pending |
Array
(
[id] => 19915229
[patent_doc_number] => 12290575
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-06
[patent_title] => Fluorescent compound comprising a fluorophore conjugated to a pH-triggered polypeptide
[patent_app_type] => utility
[patent_app_number] => 18/349855
[patent_app_country] => US
[patent_app_date] => 2023-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 65
[patent_no_of_words] => 33852
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18349855
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/349855 | Fluorescent compound comprising a fluorophore conjugated to a pH-triggered polypeptide | Jul 9, 2023 | Issued |
Array
(
[id] => 18770826
[patent_doc_number] => 20230365625
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => METHODS FOR TREATING AND/OR PREVENTING UNDESIRABLE SEQULAE OF NASAL TURBINOPLASTY OR FUNCTIONAL ENDOSCOPIC SINUS SURGERY
[patent_app_type] => utility
[patent_app_number] => 18/317075
[patent_app_country] => US
[patent_app_date] => 2023-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12780
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18317075
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/317075 | METHODS FOR TREATING AND/OR PREVENTING UNDESIRABLE SEQULAE OF NASAL TURBINOPLASTY OR FUNCTIONAL ENDOSCOPIC SINUS SURGERY | May 12, 2023 | Pending |
Array
(
[id] => 18724323
[patent_doc_number] => 20230338461
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => PHOSPHORYLCHOLINE CONJUGATES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/144387
[patent_app_country] => US
[patent_app_date] => 2023-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13649
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18144387
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/144387 | Phosphorylcholine conjugates and uses thereof | May 7, 2023 | Issued |
Array
(
[id] => 18753967
[patent_doc_number] => 20230357321
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => POLYPEPTIDE AND APPLICATION THEREOF IN BONE REPAIR
[patent_app_type] => utility
[patent_app_number] => 18/308695
[patent_app_country] => US
[patent_app_date] => 2023-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3073
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18308695
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/308695 | Polypeptide and application thereof in bone repair | Apr 27, 2023 | Issued |
Array
(
[id] => 18649451
[patent_doc_number] => 20230295263
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => SOLUBLE THY-1 COMPOSITIONS AND USE THEREOF TO TREAT OR REVERSE FIBROSIS
[patent_app_type] => utility
[patent_app_number] => 18/303796
[patent_app_country] => US
[patent_app_date] => 2023-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15268
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18303796
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/303796 | SOLUBLE THY-1 COMPOSITIONS AND USE THEREOF TO TREAT OR REVERSE FIBROSIS | Apr 19, 2023 | Abandoned |
Array
(
[id] => 18672884
[patent_doc_number] => 20230310330
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => PEPTIDIC OLIGOMERS AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/131280
[patent_app_country] => US
[patent_app_date] => 2023-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7212
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18131280
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/131280 | PEPTIDIC OLIGOMERS AND METHODS OF USING THE SAME | Apr 4, 2023 | Pending |
Array
(
[id] => 18956549
[patent_doc_number] => 20240044876
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => IDENTIFYING NEW THERAPEUTIC AGENTS
[patent_app_type] => utility
[patent_app_number] => 18/128799
[patent_app_country] => US
[patent_app_date] => 2023-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17439
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 631
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18128799
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/128799 | IDENTIFYING NEW THERAPEUTIC AGENTS | Mar 29, 2023 | Abandoned |